Although the inflammation in AMD is largely mediated through complement-associated pathways, such as CFH, CFI, C2, CFB, and C3, other mechanisms have also been reported, including age-related maculopathy susceptibility (ARMS2), which acts through a matrix metalloproteinase inhibitor. This evidence concerns the gene C3 and age-related macular degeneration.